Loading...
DOCUMENTS
20
NOTICES
33
MOTS CLES
Biologics
Upper gastrointestinal tract
Crohn’s disease
Clinical guidelines
Disability
Helicobacter pylori
Resistance
Résistance
T1118 translocation
Epigenetics
Dysbiosis
Tailored therapy
Gene expression
Monitoring
Anti-TNF
Intestinal crypts
MARKER
Therapeutics
Contraindication
Colon
Méthylation
Cost effectiveness
Fecal microbiota
Primary sclerosing cholangitis
IBD
Algorithm
Immunosuppressant
Survival
Dysbiose
Colorectal cancer Colibactin and lipids
Gènes
Kidney diseases
Stricture
DNA methylation
Alkylating agents
Cancer
IL23
Colorectal cancer
Bacteria
Thérapie ciblée
Biomarker
Eradication
Genes
Neoadjuvant chemotherapy
Methylation
Disease Progression
Colonic epithelial primary cells
Drug
MICROBIOTA
Inflammatory bowel diseases
Effectiveness
Immune cells
Endoscopic treatment
Consensus
MORTALITY
Venous thromboembolism
RISK
Parvimonas micra
Inhibitor
Tuberculosis
CARCINOGENESIS
Patient-reported outcome
Gene methylation
Microbiota
MALT
Cell adhesion
Ustekinumab
PCR
IL12
Clinical trial
Bactéries
DNA METHYLATION
18 FDG-PET/CT
Original Article Clinical
Colectomy
Small molecules
Anti-TNF agents
HIV
Over 80s
Safety
Maintenance therapy
Patients experience
Epigénétiques
Ulcerative colitis
Inflammatory Bowel Diseases
Disease progression
Rituximab plus chlorambucil
Heart disease risk factors
COLON-CANCER
Microbiote
Crohn's disease
Screening
Colon cancer
Vedolizumab
Inflammatory bowel disease
Acceptability
Rituximab
Inclusion
Eligibility
Surgery
Early detection of Colon Cancer using Molecular Markers and Microbiota , EA 7375 | |
---|---|
Institutions |
UPEC |
Adresse |
Université Paris-Est Créteil Groupe Hospitalier Henri Mondor Service de Gastroentérologie 51 Av Maréchal de Lattre de Tassigny 94010 Créteil cedex |
Courriel |
|
Site Internet |
|
Rattachement(s) |
|
Direction |
Aurélien AMIOT |
Adjoint |
Iradj SOBHANI |
Axe(s) de recherche
|
Le laboratoire axe ses recherches sur le rôle du microbiome intestinal ainsi que des changements épigénétiques dans l'intestin afin :
|